Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity

Journal of Virology

Volumn 81, Issue 2, 2007, Pages 732-742

  Rodenburg, Michaela ^a   Fischer, Meike ^a   Engelmann, Afra ^a   Harbers, Stephanie O ^a   Ziegler, Marion ^a   Löhler, Jürgen ^a   Stocking, Carol ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINEAGE; CELL SPECIFICITY; CELL TRANSFORMATION; CONTROLLED STUDY; ERYTHROLEUKEMIA; FLI1 GENE; GENE; GENE ACTIVATION; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; ICSBP GENE; INFECTION SENSITIVITY; LEUKEMOGENESIS; LONG TERMINAL REPEAT; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; MOUSE STRAIN; MURINE LEUKEMIA VIRUS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; STEM CELL; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS TRANSFORMATION; VIRUS VIRULENCE;

ANIMALS; CELLS, CULTURED; FIBROBLASTS; GENE PRODUCTS, ENV; HEMATOPOIETIC STEM CELLS; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEIN C-FLI-1; RECEPTORS, VIRUS; RETROVIRIDAE INFECTIONS; SPECIES SPECIFICITY; TUMOR VIRUS INFECTIONS;

FRIEND MURINE LEUKEMIA VIRUS; MURINE LEUKEMIA VIRUS; MUS;

EID: 33846088920     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01430-06     Document Type: Article

References (62)

1. Akagi, K., T. Suzuki, R. Stephens, N. Jenkins, and N. Copeland. 2004. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 32: D523-D527.
2. Athas, G., C. Starkey, and L. Levy. 1994. Retroviral determinants of leukemogenesis. Crit. Rev. Oncog. 5:169-199.
3. Audit, M., J. Déjardin, B. Hohl, C. Sidobre, T. Hope, M. Mougel, and M. Sitbon. 1999. Introduction of cis-acting mutation in the capsid-coding gene of Moloney murine leukemia virus extends its leukemogenic properties. J. Virol. 73:10472-10479.
4. Barat, C., and E. Rassart. 1998. Members of the GATA family of transcription factors bind to the U3 region of Cas-Br-E and graffi retroviruses and transactivate their expression. J. Virol. 72:76-84.
5. Barat, C., and E. Rassart. 1998. Nuclear factors that bind to the U3 region of the two murine myeloid leukemia-inducing retroviruses, Cas-Br-E and Graffi. Virology 252:82-95.
6. Barrette, S., J. Douglas, D. Orlic, S. Anderson, N. Seidel, A. Miller, and D. Bodine. 2000. Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors. Mol. Ther. 1:330-338.
7. Ben-David, Y., E. Giddens, and A. Bernstein. 1990. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc. Natl. Acad. Sci. USA 87: 1332-1336.
8. Ben-David, Y., E. Giddens, K. Letwin, and A. Bernstein. 1991. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:908-918.
9. Bergeron, D., L. Poliquin, J. Houde, B. Barbeau, and E. Rassart. 1992. Analysis of proviruses integrated in Fli-1 and Evi-1 regions in Cas-Br-E MuLV-induced non-T-, non-B-cell leukemias. Virology 191:661-669.
10. Blair, D., and M. Athansiou. 2000. Ets and retroviruses- transduction and activation of members of the Ets oncogene family in viral oncogenesis. Oncogene 19:6472-6481.
11. Castilla, L., P. Perrat, N. Martinez, S. Landrette, R. Keys, S. Oikemus, J. Flanegan, S. Heilman, L. Garrett, A. Dutra, S. Anderson, G. Pihan, L. Wolff, and P. Liu. 2004. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 101:4924-4929.
12. Chandhasin, C., P. Coan, I. Pandrea, C. Grant, P. Lobelle-Rich, A. Puetter, and L. Levy. 2005. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome. J. Virol. 79:5278-5287.
13. Denicourt, C., E. Edouard, and E. Rassart. 1999. Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration. J. Virol. 73:4439-4442.
14. Donahue, P., S. L. Quackenbush, M. V. Gallo, C. M. C. deNoronha, J. Overbaugh, E. A. Hoover, and J. I. Mullins. 1991. Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J. Virol. 65:4461-4469.
15. Fan, H. 1997. Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol. 5:74-82.
16. Fehse, B., O. Kustikova, M. Bubenheim, and C. Baum. 2004. Pois(s)on-it's a question of dose. Gen. Ther. 11:879-881.
17. Fischer, M., M. Schwieger, S. Horn, B. Niebuhr, A. Ford, S. Roscher, U. Bergholz, M. Greaves, J. Lohler, and C. Stocking. 2005. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model. Oncogene 24:7579-7591.
18. Golemis, E., Y. Li, T. Fredrickson, J. Hartley, and N. Hopkins. 1989. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses. J. Virol. 63:328-337.
19. Hacein-Bey-Abina, S., C. Von Kalle, M. Schmidt, M. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J. Cohen, G. de Saint Basileqq, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L. Leiva, M. Wissler, C. Prinz, T. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419.
20. Holtschke, T., J. Löhler, Y. Kanno, T. Fehr, N. Giese, F. Rosenbauer, J. Lou, K.-P. Knobeloch, L. Gabriele, J. Waring, M. Bachmann, R. Zinkernagel, H. Morse III, K. Ozato, and I. Horak. 1996. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87:307-317.
21. Jonkers, J., and A. Berns. 1996. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim. Biophys. Acta 1287:29-57.
22. Kiem, H., P. McSweeney, B. Bruno, M. Goerner, G. Buron, J. Morris, R. Storb, and A. Miller. 1999. Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector. Gene Ther. 6:966-972.
23. Kosmider, O., and F. Moreau-Gachelin. 2006. From mice to human: the "two-hit model" of leukemogenesis. Cell Cycle 5:569-570.
24. Kurre, P., H. Kiem, J. Morris, S. Heyward, J.-L. Battini, and D. Miller. 1999. Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor. J. Virol. 73:495-500.
25. Lai, M. M. C., S. Rasheed, C. S. Simizu, and M. B. Gardner. 1982. Genomic characterization of a highly oncogenic env gene recombinant between amphotropic retrovirus of wild mouse and endogenous xenotropic virus of NIH Swiss mouse. Virology 117:262-266.
26. Laker, C., J. Meyer, A. Schopen, J. Friel, W. Ostertag, and C. Stocking. 1998. Retroviruses permissive for expression in embryonic cells are subject to host cis-mediated extinction. J. Virol. 72:339-348.
27. Largaespada, D. 2000. Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies. Leukemia 14:1174-1184.
28. Lauring, A., M. Anderson, and J. Overbaugh. 2001. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants. J. Virol. 75:8888-8898.
29. MacDonald, M., T. Mak, and A. Bernstein. 1980. Erythroleukemia induction by replication-competent type C virus cloned from the anemia-polycythemia-inducing isolates of Friend leukemia virus. J. Exp. Med. 151:1493.
30. McNagny, K., and T. Graf. 1996. Acute avian leukemia viruses as tools to study hematopoietic cell differentiation. Curr. Top. Microbiol. Immunol. 212:143-162.
31. Mikkers, H., and A. Berns. 2003. Retroviral insertional mutagenesis: tagging cancer pathways. Adv. Cancer Res. 88:53-99.
32. Miller, D. G., and A. D. Miller. 1994. A family of retroviruses that utilize related phosphate transporters for cell entry. J. Virol. 68:8270-8276.
33. Morceau, F., M. Schneckenburger, M. Dicato, and M. Diederich. 2004. GATA-1: friends, brothers, and co-workers. Ann. N. Y. Acad. Sci. 1030:537-554.
34. Münk, C., V. Prassolov, S. Kalinin, J. Löhler, and C. Stocking. 2003. The neurovirulent determinants of 10A1-MuLV lie upstream of the structural Gag coding region and outside of the receptor-binding domain in Env. Virology 313:44-55.
35. Nerlov, C., and T. Graf. 1998. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12:2403-2412.
36. Ney, P., and A. D'Andrea. 2000. Friend erythroleukemia revisited. Blood 96:3675-3680.
37. Niho, Y., T. Shibuya, and T. Mak. 1982. Modulation of erythropoiesis by the helper-independent Friend luekemia virus F-MuLV. J. Exp. Med. 156:146-158.
38. Nishigaki, K., C. Hanson, T. Jelacic, D. Thompson, and S. Ruscetti. 2005. Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk. Proc. Natl. Acad. Sci. USA 102:15488-15493.
39. Orlic, D., L. Girard, C. Jordan, S. Anderson, A. Cline, and D. Bodine. 1996. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci. USA 93:11097-11102.
40. Ott, D., R. Friedrich, and A. Rein. 1990. Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses. J. Virol. 64:757-766.
41. Ott, D., J. Keller, K. Sell, and A. Rein. 1994. 10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration. Virology 205:563-568.
42. Ott, D., J. Keller, K. Sill, and A. Rein. 1992. Phenotypes of murine leukemia virus-induced tumors: influence of the 3′ viral coding sequences. J. Virol. 66:6107-6116.
43. SU. J. Virol. 66:4632-4638.
44. Persons, D., R. Paulson, M. Loyd, M. Herley, S. Bodner, A. Bernstein, P. Correll, and P. Nex. 1999. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nat. Genet. 23:159-165.
45. Ramirez, J., L. Houzet, R. Koller, J. Bies, L. Wolff, and M. Mougel. 2004. Activation of c-myb by 5′ retrovirus promoter insertion in myeloid neoplasms is dependent upon an intact alternative splice donor site (SD') in gag. Virology 330:398-407.
46. Rosenbauer, F., S. Koschmieder, U. Steidl, and D. Tenen. 2005. Effect of transcription-factor concentrations on leukemic stem cells. Blood 106:1519-1524.
47. Schwieger, M., J. Löhler, J. Friel, M. Scheller, I. Horak, and C. Stocking. 2002. AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages in induces myeloblast transformation in synergy with ICSBP deficiency. J. Exp. Med. 196:1227-1240.
48. Sels, F., S. Langer, A. Schult, J. Silver, M. Sitbon, and R. Friedrich. 1992. Friend murine leukemia virus is integrated at a common site in most primary spleen tumors of erythroleukaemic animals. Oncogene 7:643-652.
49. Short, M., S. Okenquist, and J. Lenz. 1987. Correlation of leukemogenic potential of murine retroviruses with transcriptional potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeat. J. Virol. 61:1067-1072.
50. Silver, J., and T. Fredrickson. 1983. A new gene that controls the type of leukemia induced by Friend murine leukemia virus. J. Exp. Med. 158:493-505.
51. Sorensen, K., L. Quintanilla-Martinez, S. Kunder, J. Schmidt, and F. Pedersen. 2004. Mutation of all Runx (AML/core) sites in the enhancer of T-lymphogenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns. J. Virol. 78:13216-13231.
52. Speck, N., B. Renjifo, E. Golemis, T. Fredrickson, J. Hartley, and N. Hopkins. 1990. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:233-242.
53. Tenen, D. 2003. Disruption of differentiation in human cancer: AML shows the way. Nat. Rev. Cancer 3:89-101.
54. Troxler, D., and E. Scolnick. 1978. Rapid leukemia induced by cloned Friend strain of replicating murine type-C virus. Virology 85:17.
55. Truong, A., and Y. Ben-David. 2000. The role of Fli-1 in normal cell function and malignant transformation. Oncogene 19:6482-6489.
56. Uren, A., J. Kool, A. Berns, and M. van Lohuizen. 2005. Retroviral insertional mutagenesis: past, present and future. Oncogene 24:7656-7672.
57. Van Hoeven, N. S., and A. D. Miller. 2005. Use of different but overlapping determinants in a retrovirus receptor accounts for non-reciprocal interference between xenotropic and polytropic murine leukemia viruses. Retrovirology 2:76.
58. van Lohuizen, M., and A. Berns. 1990. Tumorigenesis by slow-transforming retroviruses-an update. Biochim. Biophys. Acta 1990:213-235.
59. van Zeijl, M., S. Johann, E. Closs, J. Cunninghan, R. Eddy, T. Shows, and B. O'Hara. 1994. A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc. Natl. Acad. Sci. USA 91:1168-1172.
60. Voisin, V., C. Barat, T. Hoang, and E. Rassarat. 2006. Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus. J. Virol. 80:4026-4037.
61. Zaiman, A., A. Nieves, and J. Lenz. 1998. CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes. J. Virol. 72:3129-3137.
62. Zhang, J., M. Randall, M. Loyd, W. Li, R. Schweers, D. Person, J. Rehg, C. Noguchi, N. Ihle, and P. Ney. 2006. Role of erythropoietic receptor signaling in Friend virus-induced erythroblastosis and polycythemia. Blood 107:73-78.